Sources Andrew Huberman on Protein Myths, Peptides, and the Science of Feeling Better goop New Weight-Loss Shot Appears to Outperform Other Obesity Drugs on Market The Guardian Lillys Phase 2 Retatrutide Results Published in The New England Journal of Medicine Eli Lilly Retatrutide for Obesity: A Phase 2 Trial The New England Journal of Medicine FDAs Concerns With Unapproved GLP-1 Drugs Used for Weight Loss U.S
This altered gastric emptying can modify the entire digestive process, affecting how quickly food is broken down and absorbed throughout the gastrointestinal tract
A suspected BED can be screened using the BES, a 16-item instrument that typically takes 58 min to complete
Hold the syringe at eye level in good lighting for accuracy
People switch from semaglutide to tirzepatide for a variety of reasons, including "inadequate response, insurance changes or intolerable side effects," says Srivastava
In Phase 2 trials, the mean heart rate increase was approximately 56 beats per minutean effect most healthy individuals don't consciously notice